Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesis

Haematologica. 2023 Jan 1;108(1):290-294. doi: 10.3324/haematol.2022.281351.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antigens, CD19
  • Clonal Hematopoiesis
  • Humans
  • Immunotherapy, Adoptive / adverse effects
  • Leukemia, Myeloid, Acute* / genetics
  • Leukemia, Myeloid, Acute* / therapy
  • Lymphoma, Large B-Cell, Diffuse* / genetics
  • Lymphoma, Large B-Cell, Diffuse* / therapy
  • Receptors, Antigen, T-Cell / genetics
  • Receptors, Chimeric Antigen* / genetics
  • T-Lymphocytes

Substances

  • Receptors, Chimeric Antigen
  • Receptors, Antigen, T-Cell
  • Antigens, CD19